Calculating Patent Term Adjustment Post-Novartis

Law360, New York (February 13, 2014, 1:44 PM EST) -- On Jan. 15, 2014, the U.S. Court of Appeals for the Federal Circuit decided Novartis AG v. Lee (No. 2013-1160, 1179) and Exelixis v. Lee (2013-1175, 1198), holding that for purposes of calculating patent term adjustment, the time excluded from Patent Office B delay for filing a request for continued examination more than three years after filing ends at allowance, not the issue date of the patent. Thus, for patents that issued from such a continued examination application, the U.S. Patent and Trademark Office has been...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.